This is a news story, published by PBS, that relates primarily to John Yang news.
For more John Yang news, you can click here:
more John Yang newsFor more disease research news, you can click here:
more disease research newsFor more news from PBS, you can click here:
more news from PBSOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like disease research news, you might also like this article about
Support PBS News. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest PBS News Hour news, John Yang news, disease research news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
PBS News WeekendPBS
•64% Informative
Bowel cancer is the second -leading cause of cancer deaths worldwide, killing nearly 1 million people per year.
Two studies found using immunotherapy drugs before surgery dramatically increased the chance of curing bowel cancer in certain patients.
John Yang speaks with Dr. Vikram Reddy to learn more.
VR Score
63
Informative language
59
Neutral language
73
Article tone
formal
Language
English
Language complexity
42
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links